Astellas Pharma Inc (4503) - Medical Equipment - Deals and Alliances Profile
November 2018
85
About the Report
About the Report
Summary
Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company's product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, infectious diseases, cancer, diseases and disorders of central nervous system (CNS), and metabolic diseases, immunodeficiency diseases, and transplantation. The company is investigating enfortumab vedotin in Phase 2 and Phase 3 clinical trials for the treatment of urothelial cancer; zolbetuximab in Phase 3 clinical trials for the treatment of gastric cancer and gastroesophageal junction cancer; roxadustat in Phase 3 clinical studies for the treatment of patients with anemia associated with chronic kidney disease (CKD) in patients on dialysis and non-dialysis; fezolinetant in Phase 2a clinical trials for the treatment of menopause-related vasomotor symptoms (MR-VMS) such as hot flashes and night sweats; and gilteritinib for the treatment of for acute myeloid leukemia (AML). It operates in the Americas; Europe; and Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.
Astellas Pharma Inc (4503)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Astellas Pharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Astellas Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Astellas Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Astellas Pharma Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Euroscreen Raises USD17.8 Million in Series B Financing Round 11
Ganymed Pharmaceuticals Secures USD60.74 Million in Venture Funding 13
Partnerships 14
Astellas US and Academy of Oncology Nurse & Patient Navigators (AONN+) Enter into Partnership 14
Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 15
Qiagen Enters into Co-Development Agreement with Astellas Pharma 16
Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 17
Equity Offering 18
Advanced Cell to Raise USD30 Million in Private Placement of Shares 18
Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For USD 35 Million 19
Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For USD 1 Million 20
Asset Transactions 21
Grunenthal to Acquire Qutenza from Astellas Pharma Europe 21
Acquisition 22
Astellas Pharma Acquires Ganymed Pharma 22
Astellas Pharma Inc-Key Competitors 24
Astellas Pharma Inc-Key Employees 25
Astellas Pharma Inc-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 34
Recent Developments 35
Financial Announcements 35
Oct 31, 2018: Astellas announce financial results of for the first six months of FY2018 35
Apr 26, 2018: Astellas Reports Financial Results for FY2017 39
Jan 31, 2018: Astellas Reports Financial Results for the First Nine Months of FY2017 41
Oct 31, 2017: Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year Outlook 43
Jul 28, 2017: Astellas Reports First Quarter FY2017 Financial Results 45
Apr 27, 2017: Astellas Reports Full Year FY2016 Financial Results 47
Jan 31, 2017: Astellas Reports the First Nine Months Financial Results of FY2016 49
Corporate Communications 50
Nov 12, 2018: Astellas names Eloiza Domingo-Snyder to Head of Diversity and Inclusion 50
Sep 18, 2018: Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US 51
Aug 23, 2018: Astellas announces promotion of Rodrigo Fernandez to Vice President, Latin America 52
Jun 08, 2018: Astellas names Nahrin Marino to Vice President, Head of Ethics & Compliance Americas 53
May 15, 2018: Astellas Names Bernhardt Zeiher As New Chief Medical Officer 54
Mar 28, 2018: Astellas Appoints Tatjana Dragovic, J.D. Head of Ethics & Compliance 55
Mar 15, 2018: Astellas Names Percival Barretto-Ko President, Americas Operations 56
Mar 13, 2018: Astellas Announces Key Leadership Changes in Legal, Human Resources 57
Jan 31, 2018: Astellas Appoints Kenji Yasukawa as President and CEO 58
Jan 08, 2018: Astellas Announces Leadership Changes in Canada and U.S. 59
Dec 13, 2017: Astellas Appoints Anthony Fiordaliso to Vice President, Americas Finance 60
Dec 04, 2017: Astellas Appoints Joao Carlos de Britto as General Manager of Astellas Farma Brasil 61
Dec 01, 2017: Astellas Announces Personnel Change 62
Nov 01, 2017: Astellas Announces Leadership Changes in U.S. Health Systems Commercial Organization 63
Oct 31, 2017: Astellas Appoints Nate Crisel to Vice President, Real World Informatics & Analytics 64
Oct 30, 2017: Astellas Appoints Gary Thal, M.D., to Vice President, Specialty, Medical Affairs, Americas 65
Aug 24, 2017: Astellas Announces Personnel Changes and Organizational Changes 66
Jun 26, 2017: Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations 67
May 11, 2017: Astellas Names Shontelle Dodson Senior Vice President and Head of Medical Affairs Americas 68
Apr 28, 2017: Astellas Announces Key Leadership Promotions in Development Organization 69
Apr 27, 2017: Astellas Pharma Announces Changes of Representative Directors and Directors 70
Feb 08, 2017: Astellas Announces Changes in Management Structure and Global Function 72
Feb 08, 2017: Astellas Announces Personnel Changes and Organizational Changes 73
Legal and Regulatory 75
May 31, 2017: Astellas Announces New Global Website Launch 75
Government and Public Interest 76
May 31, 2018: Astellas Oncology C3 Prize Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World 76
Jul 05, 2017: Astellas Named to FTSE4Good Sustainability Index for the Sixth Consecutive Year 77
Other Significant Developments 78
Oct 23, 2018: Astellas and BANDAI NAMCO entertainment to jointly develop Smartphone Exercise Support App 78
Oct 09, 2018: Astellas details progress and commitment to patients and the community in the company's americas 2017 corporate social responsibility report card 79
Feb 05, 2018: Astellas Announces Changes in Management Structure, Global Function, and Top Management Committees 80
Feb 05, 2018: Astellas Announces Organizational Changes 81
Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma 82
Appendix 85
Methodology 85
About GlobalData 85
Contact Us 85
Disclaimer 85
List of Figure
List of Figures
Astellas Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Astellas Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Astellas Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Astellas Pharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Table
List of Tables
Astellas Pharma Inc, Medical Equipment, Key Facts, 2018 2
Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Astellas Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Astellas Pharma Inc, Deals By Market, 2012 to YTD 2018 9
Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Euroscreen Raises USD17.8 Million in Series B Financing Round 11
Ganymed Pharmaceuticals Secures USD60.74 Million in Venture Funding 13
Astellas US and Academy of Oncology Nurse & Patient Navigators (AONN+) Enter into Partnership 14
Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 15
Qiagen Enters into Co-Development Agreement with Astellas Pharma 16
Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 17
Advanced Cell to Raise USD30 Million in Private Placement of Shares 18
Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For USD 35 Million 19
Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For USD 1 Million 20
Grunenthal to Acquire Qutenza from Astellas Pharma Europe 21
Astellas Pharma Acquires Ganymed Pharma 22
Astellas Pharma Inc, Key Competitors 24
Astellas Pharma Inc, Key Employees 25
Astellas Pharma Inc, Other Locations 28
Astellas Pharma Inc, Subsidiaries 28
Astellas Pharma Inc, Joint Venture 34
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.